
Written based on 26 research studies on PubMed, searched on 2026. nov. 11..
The claim
Posts online say that omega-3 fatty acids (fish oil) helps with schizophrenia.
Where research stands
We found 99 published papers on omega-3 fatty acids (fish oil) and schizophrenia. They were published between 1981 and 2026. 25 of them are studies in people. 23 of them compared people who got it with a group that did not. 10 were studies in animals, and none was only in cells in the lab. 26 papers are reviews that sum up other studies. 1 new study in people is running or will start soon, say the trial registers.
- 25In people23 with a comparison group
- 10In animals
- 0Only in the lab
What the studies found
We have not summed up these studies in words yet. The most important papers are listed under Sources.
Verdict
Omega-3 fatty acids (fish oil) has been tested in randomised trials in people with schizophrenia.
What this means for you: A study in people is not proof that it helps you. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study.2021 · Schizophr Res · Randomised trial
- No Impact of Omega-3 Fatty Acid Supplementation on Symptoms or Hostility Among Patients With Schizophrenia.2020 · Front Psychiatry · Randomised trial
- Omega-3 fatty acids ameliorate cognitive dysfunction in schizophrenia patients with metabolic syndrome.2020 · Brain Behav Immun · Randomised trial
- Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial.2019 · Psychopharmacology (Berl) · Randomised trial
- A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone.2019 · Schizophr Res · Randomised trial
- Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate.2018 · Psychiatry Res · Randomised trial
- Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study.2018 · Schizophr Res · Randomised trial
- Neurocognitive effects of an omega-3 fatty acid and vitamins E+C in schizophrenia: A randomised controlled trial.2018 · Prostaglandins Leukot Essent Fatty Acids · Randomised trial
- A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.2017 · Trials · Study in people
- NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.2017 · Early Interv Psychiatry · Study in people
- Omega-3 Polyunsaturated Fatty Acids as Adjunctive Therapy to Antipsychotic Treatment in Adults with Schizophrenia: A Systematic Review and Meta-Analysis.2026 · Brain Sci · Review
- The therapeutic effect of omega-3 polyunsaturated fatty acids on symptom severity of psychosis: A systematic review and meta-analysis.2024 · Eur Psychiatry · Review
- A Systematic Review of Effectiveness of Omega-3 Fatty Acid Supplementation on Symptoms, Social Functions, and Neurobiological Variables in Schizophrenia.2021 · Biol Res Nurs · Review
- Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?2021 · Int J Mol Sci · Review
- Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials.2021 · J Psychopharmacol · Review
- Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.2020 · Lipids Health Dis · Review
- Prenatal omega-3 fatty acids supplementation mitigates some schizophrenia-like deficits in offspring: A PET and MRI study in a rat model.2025 · Transl Psychiatry · In animals
- Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I:C Rat Model.2023 · Antioxidants (Basel) · In animals
- Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C.2021 · Eur Neuropsychopharmacol · In animals
- Celecoxib and omega-3 fatty acids alone and in combination with risperidone affect the behavior and brain biochemistry in amphetamine-induced model of schizophrenia.2016 · Biomed Pharmacother · In animals
- Effects of omega-3 supplementation on interleukin and neurotrophin levels in an animal model of schizophrenia.2015 · An Acad Bras Cienc · In animals
- Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizophrenia.2015 · Life Sci · In animals
- Correlations between omega-3 fatty acids and inflammatory/glial abnormalities: the involvement of the membrane and neurotransmitter dysfunction in schizophrenia.2023 · Front Cell Neurosci · Other paper
- Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid.2023 · Front Psychiatry · Other paper
- Determining nonesterified and total docosahexaenoic acid and eicosapenaenoic acid concentrations by LC-MS/MS in the plasma of patients with schizophrenia.2022 · Bioanalysis · Other paper
- Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia.2021 · Int J Neuropsychopharmacol · Other paper


